You are here

  • Home
  • Archive
  • Volume 67, Issue 8
  • Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

Article info

Article menu

Download PDFPDF

Extended report
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

Authors

  1. Harry K Genant, University of California, San Francisco, San Francisco, CA, USA; harry.genant{at}ucsf.edu
View Full Text

Citation

Genant HK, Peterfy CG, Westhovens R, et al
Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial
Annals of the Rheumatic Diseases 2008;67:1084-1089.

Publication history

  • Accepted November 17, 2007
  • First published December 17, 2007.
Online issue publication 
October 25, 2017

Article Versions

Copyright information

2008 BMJ Publishing Group and European League Against Rheumatism